Care Transition Intervention for Patients With Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced Cancer
- Home Care, Hospital-Based
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is a single-site, single-arm pilot trial to assess the feasibility and acceptability of a CONTINUUM-V for patients with advanced cancer The research study procedures include: A video visit with a nurse practitioner within three business days of hospital discharge Questionnaires asking about dem...
This is a single-site, single-arm pilot trial to assess the feasibility and acceptability of a CONTINUUM-V for patients with advanced cancer The research study procedures include: A video visit with a nurse practitioner within three business days of hospital discharge Questionnaires asking about demographic information (e.g. sex, ethnicity, income) and participant experience with cancer (e.g. symptoms and confidence in managing their health condition) A satisfaction survey to assess the participants' impressions of the intervention and any suggestions the participants may have Data collection from their medical record One time interview of participant and clinician for feedback on CONTINUUM-V Participants will be in this research study for up to 45 days after hospital discharge. It is expected that about 55 people, including patients and clinicians, will take part in this research study. The Conquer Cancer Foundation and the Rising Tide Foundation for Clinical Cancer Research are supporting this research study by providing a Career Pathway Grant in Symptom Management to support the research team.
Tracking Information
- NCT #
- NCT04640714
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jennifer S Temel, MD Massachusetts General Hospital